Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningBone MarrowTransplantation, AutologousBone Marrow CellsWhole-Body IrradiationHematologic NeoplasmsTransplantation ChimeraTissue DonorsLiver TransplantationStem Cell TransplantationHistocompatibility TestingMyeloablative AgonistsGraft SurvivalLeukemiaHistocompatibilityBusulfanHematopoietic Stem CellsTreatment OutcomeAnemia, AplasticUnrelated DonorsKidney TransplantationPeripheral Blood Stem Cell TransplantationRecurrenceBone and BonesLeukemia, Myeloid, AcuteRetrospective StudiesImmunosuppressive AgentsRemission InductionSurvival AnalysisCord Blood Stem Cell TransplantationGraft RejectionCombined Modality TherapyGraft vs Tumor EffectCyclophosphamideHematopoiesisTime FactorsHLA AntigensTransplantation ImmunologySurvival RateTransplantation, IsogeneicLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Leukemia EffectPrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic SyndromesBone Marrow PurgingHeart TransplantationDisease-Free SurvivalChimerismVidarabineHematologic DiseasesMice, Inbred C57BLHepatic Veno-Occlusive DiseaseCell TransplantationImmunosuppressionAcute DiseaseLymphoma, Non-HodgkinLung TransplantationSiblingsFollow-Up StudiesCyclosporineT-LymphocytesLymphocyte DepletionLymphocyte TransfusionBone Marrow DiseasesLeukemia, MyeloidTransplantationAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaSevere Combined ImmunodeficiencyOrgan TransplantationRadiation ChimeraCytomegalovirus InfectionsDonor SelectionPrognosisFlow CytometryAntilymphocyte SerumLiving DonorsAntineoplastic AgentsCell DifferentiationColony-Forming Units AssayAntigens, CD34Bone Marrow ExaminationRisk FactorsMice, Inbred BALB CIslets of Langerhans TransplantationLymphomaMinor Histocompatibility AntigensMelphalanGraft vs Host ReactionLeukocyte TransfusionHodgkin DiseaseSurvivorsBone Marrow NeoplasmsChimeraPancreas TransplantationNeoplasms